India's Doctors Warn of Unregulated Weight Loss Jab Boom

Indian doctors are raising alarms over the rapid surge and unregulated use of weight loss injections like Mounjaro, Wegovy, and Ozempic. While the drugs address India's growing obesity and diabetes crisis, experts warn of severe side effects and potential misuse without strict guidelines. The government is drafting national guidelines to address these concerns.

• Weight loss jabs like Mounjaro and Ozempic are experiencing a significant boom in India.
• Mounjaro has become India's highest-selling drug, surpassing antibiotics.
• Doctors warn of unregulated use, misuse for cosmetic purposes, and severe side effects.
• Concerns include muscle loss, pancreatitis, gallstones, and potential vision-related complications.
• India is drafting national guidelines to regulate GLP-1 drugs for obesity management.
• Patent expiry for semaglutide by March 2026 is expected to flood the market with cheaper generics.

Read the full story on Quick Digest.